Astellas US LLC, the US subsidiary of the Japanese drug major Astellas Pharma, has sued the Mumbai-based Wockhardt Ltd and its US subsidiary for alleged infringement of its patent on pharmacological stress agent Adenoscan - adenosine injection - as the latter has filed an abbreviated new drug application (ANDA) for generic version of the product.
The details can be read here.
No comments:
Post a Comment